Most Recent
A judge has rejected Aristocrat’s bid for orders requiring competitor Light & Wonder to hand over documents to be placed “in an envelope” for speedy production should its appeal of a decision ordering that it produce the documents to Aristocrat for possible trade secrets suit fail.
The Australian Securities and Investments Commission has prevailed in its case against payday lenders Cigno and BSF Solutions alleging they provided credit without a licence, with a judge rejecting their argument that their loan model was analogous to buy now, pay later arrangements that don’t require a credit licence.
The auditors of self-managed superannuation funds that clients of Melissa Caddick invested with the Sydney fraudster and her company Maliver have hit back at class action claims, saying the clients have themselves to blame for handing over “direct control” of their funds.
A former Ord Minnett executive has taken the wealth management firm to court alleging he was sacked for complaining about a $110,000 cut in his pay imposed after the corporate regulator slapped the firm with a $880,000 penalty for breaching market integrity rules.
A class action against Toyota alleging it installed diesel defeat devices in several models of its vehicles has lost a bid to access source code for the cars’ emissions control systems, with a judge finding it was not relevant to any current fact in issue.
A lawsuit accusing Netflix of violating the Fair Work Act by making an employee's position redundant while she was on parental leave has been sent to mediation.
Australia’s largest brick manufacturer Brickworks has accused a rival founded by billionaire Len Buckeridge of substantially lessening competition in Western Australia through a 2021 acquisition and engaging in predatory pricing that caused it to shut its doors in the state.
The chair of the Medibank board has given evidence that he engaged King & Wood Mallesons to commission expert reviews in the wake of a cyberattack, including three reports by Deloitte, after hearing rumours of class action investigations in October 2022.
Challenging a ruling that it breached its continuous disclosure obligations, ANZ has argued on appeal that it did not need to inform the ASX of a bailout by the underwriters of a 2015 institutional share placement because the information didn’t go to the fundamental value of its shares.
South Korean biotech ToolGen has won court approval to patent its genome editing technology CRISPR, after an earlier bid to protect its IP found the revolutionary technology was not patentable.